CLONAZEPAM

Clonazepam Adverse Events Reported to the FDA Over Time

How are Clonazepam adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Clonazepam, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Clonazepam is flagged as the suspect drug causing the adverse event.

Most Common Clonazepam Adverse Events Reported to the FDA

What are the most common Clonazepam adverse events reported to the FDA?

Completed Suicide	1220 (4.61%)
Cardiac Arrest	592 (2.24%)
Respiratory Arrest	537 (2.03%)
Death	365 (1.38%)
Cardio-respiratory Arrest	364 (1.38%)
Drug Ineffective	331 (1.25%)
Overdose	325 (1.23%)
Somnolence	274 (1.04%)
Anxiety	271 (1.02%)
Suicide Attempt	265 (1%)
Convulsion	227 (.86%)
	Show More
Confusional State	218 (.82%)
Dizziness	216 (.82%)
Hypotension	213 (.81%)
Insomnia	211 (.8%)
Drug Interaction	194 (.73%)
Poisoning	193 (.73%)
Headache	192 (.73%)
Fatigue	190 (.72%)
Drug Toxicity	186 (.7%)
Agitation	185 (.7%)
Tremor	184 (.7%)
Depression	182 (.69%)
Intentional Overdose	155 (.59%)
Multiple Drug Overdose Intentional	155 (.59%)
Fall	152 (.57%)
Multiple Drug Overdose	151 (.57%)
Suicidal Ideation	149 (.56%)
Nausea	144 (.54%)
Drug Abuse	138 (.52%)
Drug Exposure During Pregnancy	138 (.52%)
Pyrexia	134 (.51%)
Feeling Abnormal	131 (.5%)
Asthenia	130 (.49%)
Drug Withdrawal Syndrome	125 (.47%)
Coma	123 (.46%)
Vomiting	121 (.46%)
Malaise	120 (.45%)
Intentional Drug Misuse	118 (.45%)
Loss Of Consciousness	118 (.45%)
Condition Aggravated	114 (.43%)
Depressed Level Of Consciousness	114 (.43%)
Dyspnoea	104 (.39%)
Decreased Appetite	96 (.36%)
Disorientation	96 (.36%)
Pain	95 (.36%)
Tachycardia	95 (.36%)
Speech Disorder	93 (.35%)
Weight Decreased	92 (.35%)
Gait Disturbance	91 (.34%)
Hyperhidrosis	89 (.34%)
Drug Dependence	87 (.33%)
Pruritus	86 (.33%)
Aggression	85 (.32%)
Balance Disorder	84 (.32%)
Diarrhoea	82 (.31%)
Hallucination	82 (.31%)
Blood Creatine Phosphokinase Increa...	79 (.3%)
Amnesia	78 (.29%)
Irritability	78 (.29%)
Hypertension	75 (.28%)
Bradycardia	74 (.28%)
Arthralgia	73 (.28%)
Mental Status Changes	72 (.27%)
Sleep Disorder	72 (.27%)
Heart Rate Increased	69 (.26%)
Unresponsive To Stimuli	69 (.26%)
Constipation	68 (.26%)
Paraesthesia	68 (.26%)
Rash	68 (.26%)
Dysarthria	67 (.25%)
Sedation	67 (.25%)
Medication Error	66 (.25%)
Nervousness	66 (.25%)
Withdrawal Syndrome	66 (.25%)
Delirium	65 (.25%)
Disturbance In Attention	65 (.25%)
Product Substitution Issue	64 (.24%)
Weight Increased	62 (.23%)
Hypoaesthesia	61 (.23%)
Restlessness	61 (.23%)
Aspartate Aminotransferase Increase...	60 (.23%)
Neuroleptic Malignant Syndrome	60 (.23%)
Muscle Spasms	59 (.22%)
Therapeutic Agent Toxicity	58 (.22%)
Abdominal Pain	57 (.22%)
Alanine Aminotransferase Increased	57 (.22%)
Lethargy	56 (.21%)
Nightmare	56 (.21%)
Dry Mouth	55 (.21%)
Dyskinesia	55 (.21%)
Memory Impairment	55 (.21%)
Respiratory Depression	55 (.21%)
Grand Mal Convulsion	54 (.2%)
Renal Failure Acute	54 (.2%)
Rhabdomyolysis	53 (.2%)
Vision Blurred	53 (.2%)
Crying	52 (.2%)
Myalgia	52 (.2%)
Serotonin Syndrome	52 (.2%)
Hypotonia	51 (.19%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Clonazepam, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Clonazepam is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Clonazepam

What are the most common Clonazepam adverse events reported to the FDA?

Neurological	2103 (7.95%)
Suicidal And Self-injurious Behavio...	1701 (6.43%)
Cardiac Arrhythmias	1373 (5.19%)
Medication Errors	1092 (4.13%)
Respiratory	1082 (4.09%)
Therapeutic And Nontherapeutic Effe...	891 (3.37%)
Anxiety Disorders	704 (2.66%)
Chemical Injury And Poisoning	656 (2.48%)
Psychiatric	568 (2.15%)
Gastrointestinal Signs	535 (2.02%)
Epidermal And Dermal Conditions	502 (1.9%)
	Show More
Movement Disorders	478 (1.81%)
Sleep Disorders	438 (1.66%)
Fatal Outcomes	418 (1.58%)
Seizures	388 (1.47%)
Deliria	379 (1.43%)
Cardiac And Vascular Investigations	347 (1.31%)
Muscle	345 (1.3%)
Injuries	343 (1.3%)
Decreased And Nonspecific Blood Pre...	294 (1.11%)
Mental Impairment	283 (1.07%)
Depressed Mood Disorders	275 (1.04%)
Hepatic And Hepatobiliary	260 (.98%)
Disturbances In Thinking	259 (.98%)
Infections - Pathogen Unspecified	255 (.96%)
Physical Examination Topics	231 (.87%)
Mood Disorders	220 (.83%)
Headaches	217 (.82%)
Neuromuscular	208 (.79%)
Hepatobiliary	206 (.78%)
Gastrointestinal Motility And Defec...	195 (.74%)
Musculoskeletal And Connective Tiss...	193 (.73%)
Lifestyle Issues	191 (.72%)
Body Temperature Conditions	190 (.72%)
Personality Disorders	185 (.7%)
Hematology Investigations	179 (.68%)
Ocular Neuromuscular	179 (.68%)
Appetite And General Nutritional	174 (.66%)
Vision	174 (.66%)
Metabolic, Nutritional And Blood Ga...	163 (.62%)
Renal Disorders	161 (.61%)
Urinary Tract Signs	159 (.6%)
Lower Respiratory Tract Disorders	146 (.55%)
Enzyme	140 (.53%)
Electrolyte And Fluid Balance Condi...	137 (.52%)
Skin Appendage Conditions	137 (.52%)
Joint	130 (.49%)
Cardiac Disorder Signs	124 (.47%)
Toxicology And Therapeutic Drug Mon...	123 (.46%)
Product Quality Issues	121 (.46%)
Changes In Physical Activity	116 (.44%)
White Blood Cell	116 (.44%)
Water, Electrolyte And Mineral	103 (.39%)
Renal And Urinary Tract Investigati...	96 (.36%)
Glucose Metabolism Disorders	91 (.34%)
Schizophrenia And Other Psychotic	87 (.33%)
Manic And Bipolar Mood Disorders	86 (.33%)
Inner Ear And Viiith Cranial Nerve	85 (.32%)
Abortions And Stillbirth	84 (.32%)
Central Nervous System Vascular	83 (.31%)
Vascular Hypertensive	77 (.29%)
Anemias Nonhemolytic And Marrow Dep...	74 (.28%)
Musculoskeletal And Connective Tiss...	73 (.28%)
Therapeutic Procedures And Supporti...	73 (.28%)
Allergic Conditions	70 (.26%)
Oral Soft Tissue Conditions	69 (.26%)
Vascular	69 (.26%)
Salivary Gland Conditions	67 (.25%)
Eye	66 (.25%)
Cardiac And Vascular Disorders Cong...	64 (.24%)
Sexual Function And Fertility	64 (.24%)
Psychiatric And Behavioural Symptom...	62 (.23%)
Pulmonary Vascular	59 (.22%)
Viral Infectious	59 (.22%)
Coronary Artery	57 (.22%)
Acid-base	56 (.21%)
Pregnancy, Labour, Delivery And Pos...	56 (.21%)
Musculoskeletal And Connective Tiss...	55 (.21%)
Neurological, Special Senses And Ps...	55 (.21%)
Myocardial	54 (.2%)
Encephalopathies	53 (.2%)
Neonatal And Perinatal Conditions	53 (.2%)
Obstetric And Gynecological Therape...	52 (.2%)
Cranial Nerve Disorders	50 (.19%)
Ocular Infections, Irritations And ...	50 (.19%)
Dissociative	49 (.19%)
Maternal Complications Of Labour An...	48 (.18%)
Bacterial Infectious	42 (.16%)
Hematological And Lymphoid Tissue T...	42 (.16%)
Increased Intracranial Pressure And...	42 (.16%)
Lipid Analyses	42 (.16%)
Menstrual Cycle And Uterine Bleedin...	42 (.16%)
Sexual Dysfunctions, Disturbances A...	42 (.16%)
Procedural And Device Related Injur...	41 (.15%)
Bone And Joint Injuries	40 (.15%)
Hypothalamus And Pituitary Gland	40 (.15%)
Legal Issues	40 (.15%)
Arteriosclerosis, Stenosis, Vascula...	39 (.15%)
Sleep Disturbances	38 (.14%)
Gastrointestinal Conditions	36 (.14%)
Vascular Hemorrhagic	36 (.14%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Clonazepam, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Clonazepam is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.